Lupus Capital PLC LUP Holding(s) in Company
Lupus Capital PLC (LUP) - Holding(s) in Company
RNS Number : 3685S
Lupus Capital PLC
29 November 2012
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying
issuer
of existing shares to which voting rights Lupus Capital plc
are
attached:
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please
specify):
3. Full name of person(s)
subject to the Aviva plc & its subsidiaries
notification obligation:
Registered Holder:
BNY (Nominees) Limited
128,166*
BNY Norwich Union Nominees Limited 2,043,333*
Chase (GA Group) Nominees Limited 11,666,877*
4. Full name of
shareholder(s) Chase Nominees Limited
(if different from 3.): 318,366*
Vidacos Nominees Limited
95,587*
*denotes direct interest
Chase Nominees Limited
272,597
5. Date of the transaction
and date on
which the threshold is 28 November 2012
crossed or
reached:
6. Date on which issuer 29 November 2012
notified:
7. Threshold(s) that is/are
crossed or 11% to 10% Change at Direct Interest Level
reached:
8. Notified details:
A: Voting rights attached to shares
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible Number Number Number Number of voting % of voting
using of of of shares rights rights
the ISIN Shares Voting
CODE Rights Direct Direct Indirect Direct Indirect
Ordinary
Shares 14,921,812 14,921,812 14,524,926 14,252,329 272,597 10.99% 0.21%
GB00B29H4253
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
be
acquired if the
instrument is
exercised/
converted.
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/ Number of % of voting
financial price date Conversion voting rights rights
instrument period instrument
refers to
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
14,524,926 11.20%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
The voting rights are managed and controlled by Aviva Investors Global
Services Limited, with the following chain of controlled undertakings:-
Aviva Investors Global Services Limited:
· Aviva plc (Parent Company)
· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)
· Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva
Group Holdings Limited)
· Aviva Investors Global Services Limited (wholly owned subsidiary of
Aviva Investors Holdings Limited)
Proxy Voting:
10. Name of the proxy holder: See Section 4
11. Number of voting rights proxy holder will
cease
to hold:
12. Date on which proxy holder will cease to
hold
voting rights:
13. Additional Figures are based on a total number of voting rights
information: of 129,668,337, as per the Company's Securities in
Issue as at 20 April 2012, disclosed in accordance
with Rule 26 of the AIM Rules
14. Contact name: Diane Thirkettle, Aviva plc
15. Contact telephone 01603 687803
number:
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLPGGMAGUPPGQB -0- Nov/29/2012 16:58 GMT
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement
Rate this Page